Akari Therapeutics (AKTX) vs Universe Pharmaceuticals (UPC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Universe Pharmaceuticals (UPC) has outperformed Akari Therapeutics (AKTX) over the past year, losing 16.7% versus a loss of 79.5%. Over five years, AKTX leads with a -99.3% price change compared with -99.9% for UPC. Universe Pharmaceuticals is the larger company by market cap ($21.4 million vs $19.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKTX | UPC |
|---|---|---|
| Share price | $8.48 | $4.26 |
| Market cap | $19.38M | $21.38M |
| 1-day change | -1.68% | -3.30% |
| YTD return | -25.39% | +12.99% |
| 1-year return | -79.46% | -16.73% |
| 5-year return | -99.35% | -99.95% |
| EPS (TTM) | $0.00 | $-1.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.80 | $17.96 |
| 52-week low | $3.02 | $2.00 |
| Distance from 52-week high | -80.19% | -76.31% |
| Average volume | 60.35K | 789.35K |
| Shares outstanding | 2.29M | 5.01M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UPC has outperformed AKTX by 62.7 percentage points over the past year.
AKTX vs UPC FAQ
Which is bigger, Akari Therapeutics or Universe Pharmaceuticals?
Universe Pharmaceuticals (UPC) is larger, with a market capitalization of $21.38M compared with $19.38M for Akari Therapeutics (AKTX).
Which stock has performed better over the past year, AKTX or UPC?
UPC returned -16.73% over the past 12 months, compared with -79.46% for AKTX (price return, excluding dividends). Past performance does not predict future results.
Are Akari Therapeutics and Universe Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.